University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

TeamSTEPPS in School Mental Health

Not Applicable

Completed

Conditions: Multidisciplinary Communication
Interprofessional Relations
Child Behavior Problem

Interventions: Behavioral: TeamSTEPPS

First Posted Date: 2020-06-19

Last Posted Date: 2024-05-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 90

Registration Number: NCT04440228

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging

Not Applicable

Recruiting

Conditions: Neurological Disorder
Hydrocephalus

Interventions: Device: Hyperfine MRI scan

First Posted Date: 2020-06-17

Last Posted Date: 2024-08-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 100

Registration Number: NCT04436068

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF

Phase 4

Completed

Conditions: Heart Failure with Preserved Ejection Fraction
Hypertension

Interventions: Drug: Metoprolol Succinate
Drug: Amlodipine Besylate

First Posted Date: 2020-06-17

Last Posted Date: 2025-01-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 50

Registration Number: NCT04434664

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Neuroendocrine and Adrenal Tumors

Not yet recruiting

Conditions: Neuroendocrine Tumors
Adrenal Tumor

Interventions: Other: No intervention

First Posted Date: 2020-06-16

Last Posted Date: 2024-10-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 999

Registration Number: NCT04432532

Incentives to Promote Sustained Linkage to HIV Care

Not Applicable

Completed

Conditions: Human Immunodeficiency Virus
HIV/AIDS

Interventions: Behavioral: Provision of HIV self-screen kit with incentives and linkage promotion

First Posted Date: 2020-06-16

Last Posted Date: 2022-07-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 99

Registration Number: NCT04431154

Locations: 🇿🇦
Ezintsha Clinical Research Center, Johannesburg, Gauteng, South Africa

Evaluating Cascade Communication Methods

Recruiting

Conditions: BRCA2 Mutation
BRCA1 Mutation

First Posted Date: 2020-06-11

Last Posted Date: 2024-04-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 100

Registration Number: NCT04428736

Locations: 🇺🇸
Abramson Cancer Center, Philadelphia, Pennsylvania, United States

Retreatment With CTL019/CTL119

Phase 1

Not yet recruiting

Conditions: Lymphoma, B-Cell

Interventions: Drug: CD19 redirected autologous T cells (CTL019 or CTL119 cells)

First Posted Date: 2020-06-09

Last Posted Date: 2024-08-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 12

Registration Number: NCT04419909

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Project Resurgence Communication Trial

Not Applicable

Completed

Conditions: Communication Research

Interventions: Other: Communication type

First Posted Date: 2020-06-05

Last Posted Date: 2021-10-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11120

Registration Number: NCT04418947

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Eating Condition

First Posted Date: 2020-06-04

Last Posted Date: 2020-06-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 17

Registration Number: NCT04414644

Locations: 🇺🇸
Center for Weight and Eating Disorders, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Cyclosporine in Patients With Moderate COVID-19

Phase 1

Completed

Conditions: COVID-19

Interventions: Drug: Cyclosporine

First Posted Date: 2020-06-02

Last Posted Date: 2022-01-11

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 11

Registration Number: NCT04412785

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy